You are here

Article Text

Article menu
Download PDFPDF
Surgeon’s Corner
Robotically Assisted Para-aortic Lymphadenectomy: Surgical Results
  1. Delphine Hudry, MD*,¶¶,
  2. Sarfraz Ahmad, PhD†,
  3. Vanna Zanagnolo, MD‡,
  4. Fabrice Narducci, MD§,
  5. Maxime Fastrez, MD∥,,
  6. Jordi Ponce, MD, PhD#,
  7. Elisabeth Tucher, MD**,
  8. Fabrice Lécuru, MD, PhD††,
  9. Vanessa Conri, MD‡‡,
  10. Pierre Leguevaque, MD, PhD§§,
  11. Frédéric Goffin, MD, PhD∥∥,
  12. Robert W. Holloway, MD† and
  13. Eric Lambaudie, MD, PhD¶¶
  1. *Georges-François Leclerc Cancer Center, Dijon, France;
  2. †Florida Hospital Cancer Institute, Orlando, FL;
  3. ‡European Institute of Oncology, Milan, Italy;
  4. §Centre Oscar Lambret, Lille, France;
  5. ∥St Pierre University Hospital, Brussels, Belgium;
  6. UZ Leuven, Leuven, Belgium;
  7. #Institute of Oncology, IDIBELL, Idibell, Spain;
  8. **Charité University Medicine, Berlin, Germany;
  9. ††European Hospital, Paris, France;
  10. ‡‡University Hospital, Bordeaux, France;
  11. §§Claudius Regaud Institute, Toulouse, France;
  12. ∥∥Citadelle Hospital, Liège, Belgium; and
  13. ¶¶Paoli Calmettes Institute, Marseille, France.
  1. Address correspondence and reprint requests to Delphine Hudry, MD, PhD, Département de Chirurgie Oncologique, Georges-François Leclerc Cancer Center, Dijon, France. E-mail: hudrynina@gmail.com.

Abstract

Objectives The aim of this study was to evaluate perioperative outcomes of robotic-assisted laparoscopic para-aortic lymphadenectomy (PAL) in patients with gynecologic cancers during the learning phases of robotic surgery programs and to compare results of extraperitoneal versus transperitoneal approaches of PAL.

Materials and Methods This study is a retrospective multicentric study of patients who underwent robotically assisted laparoscopic PAL (N = 487). Eleven European centers and 1 US center participated in the study. Abstracted data included age, body mass index, indication, type of surgical approach (transperitoneal or extraperitoneal), associated surgical procedures, operative time, estimated blood loss, lymph node count, hospital length of stay (LOS), and complications. Para-aortic lymphadenectomy was performed by an extraperitoneal approach in 58 cases (12%) and transperitoneal in 429 cases (88%).

Results The mean (SD) para-aortic lymph node count was 12.6 (8.1), operative time was 217 (85) minutes, estimated blood loss was 105 (110) mL, and LOS was 2.8 (3.2) days. Four (0.8%) conversions to open and 2 (0.4%) conversions to laparoscopy were described. There were 32 lymphocysts (6.6%), 3 deep venous thromboses (0.6%), and 10 transfusions (2.1%). For transperitoneal approach, the average number of lymph nodes removed was higher in isolated PAL group than the hysterectomy combined group (report node counts 95% confidence interval, −7.29 to −3.52, P = 1.5 × 10−6). For isolated PAL, the LOS was shorter in the extraperitoneal group than in the transperitoneal group (report data 95% CI, −1.35 to −0.35, P = 0.001).

Conclusions Robotic-assisted PAL seems safe and feasible. More lymph nodes were removed during an isolated transperitoneal PAL dissection compared with a combined procedure with hysterectomy. Extraperitoneal approach seems attractive relative to transperitoneal dissection, but the superiority of one or the other way is not demonstrated by our study.

  • Robotic surgery
  • Para-aortic lymphadenectomy
  • Surgical outcomes
  • Endometrial cancer
  • Cervical cancer

https://doi.org/10.1097/IGC.0000000000000373

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • The SERGS collaborative group includes Christhardt Köhler, Eric Leblanc, Angelo Maggioni, Ignace Vergote and Gilles Houvenaeghel. Robert W. Holloway is a training consultant for Intuitive Surgical, Inc, Sunnyvale, CA. Eric Lambaudie is a proctor for Intuitive Surgical, Inc, France. The remaining authors have no conflicts of interest or financial ties associated with this article to disclose.